000 | 01000 a2200289 4500 | ||
---|---|---|---|
005 | 20250513043428.0 | ||
264 | 0 | _c19950718 | |
008 | 199507s 0 0 eng d | ||
022 | _a0028-3878 | ||
024 | 7 |
_a10.1212/wnl.45.6.1233 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChamberlain, M C | |
245 | 0 | 0 |
_aCNS lymphoma. _h[electronic resource] |
260 |
_bNeurology _cJun 1995 |
||
300 |
_a1233 p. _bdigital |
||
500 | _aPublication Type: Comment; Letter | ||
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 |
_aCentral Nervous System Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aCyclophosphamide _xtherapeutic use |
650 | 0 | 4 |
_aDoxorubicin _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLymphoma _xdrug therapy |
650 | 0 | 4 |
_aPrednisone _xtherapeutic use |
650 | 0 | 4 |
_aVincristine _xtherapeutic use |
773 | 0 |
_tNeurology _gvol. 45 _gno. 6 _gp. 1233 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1212/wnl.45.6.1233 _zAvailable from publisher's website |
999 |
_c7783268 _d7783268 |